Aytu Biopharma (AYTU) CEO pay: $867,093 actually paid in FY2025
$AYTU · AYTU BIOPHARMA, INCData through FY2025 — latest proxy filed 2025-10-24, checked for new filings 2026-08-21. Every number links to its source.
0.2× the tracked-company median CEO pay ($3.9M).
Pay vs. Performance (Compensation Actually Paid)
What the CEO was actually paid, by fiscal year
What $100 invested was worth, company vs peer group
Pay-vs-Performance table
| FY | CEO pay on paper | CEO pay actually earned | Other top execs (avg) | Value of $100 invested since FY2023 | Same, peer group since FY2023 | Net income |
|---|---|---|---|---|---|---|
| 2025 | $883,928 | $867,093 | $443,461 | $15.80 | — | -$13.6M |
| 2024 | $928,217 | $919,184 | $564,935 | $21.10 | — | -$15.8M |
| 2023 | $708,000 | $391,846 | $408,918 | $11.50 | — | -$17.1M |
Frequently asked
How much did the AYTU CEO make in 2025?
$867,093 in Compensation Actually Paid (CAP) as AYTU BIOPHARMA, INC's CEO (the filing reports this year's PEO pay without tagging which named executive it belongs to), updated 2025-10-24.
What is pay vs. performance (PvP)?
An SEC disclosure (Item 402(v), required since FY2022) linking named-executive pay to company total shareholder return (TSR) over up to 5 years.
What is Compensation Actually Paid (CAP)?
CAP starts from the Summary Compensation Table total and adjusts equity awards to fair value as of each year-end/vesting date, rather than grant-date value — see the glossary entry for the full walk-through.
Also on AYTU: SEC & DOJ enforcement actions · CEO track-record ranking · Glossary